FDA Drug Application (204031) for XARTEMIS XR by MALLINCKRODT INC

Back to FDA Applications sponsored by MALLINCKRODT INC

Application Number204031
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage325MG;7.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXARTEMIS XR
Active IngredientACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient ACETAMINOPHEN107
List of drugs with Active Ingredient OXYCODONE HYDROCHLORIDE27


Back to FDA Applications sponsored by MALLINCKRODT INC